Advertisement
Screener

CRESCENT BIOPHARMA, INC. (CBIO) Net Margin

CRESCENT BIOPHARMA, INC. (CBIO) Net Margin

  • 2026-03-31: Net Margin -2240.90%.
  • 2022-06-30: Net Margin -17690.09%.
  • 2021-12-31: Net Margin -98847.07%.
  • 2021-09-30: Net Margin -20023.48%.

Complete source-backed net margin history.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Net Margin

DateNet Margin
2026-03-31-2240.90%
2022-06-30-17690.09%
2021-12-31-98847.07%
2021-09-30-20023.48%
2021-06-30-10140324.65%
2021-03-31-1352.43%
2020-12-31-9551.50%
2020-09-30-1372.25%
2020-03-31-85.14%
2016-09-30-42457.80%
2015-12-31-25107.29%
2015-06-3051.86%
2014-06-3053.18%
2013-12-31-4995.71%
2013-09-30-7039.78%
2013-06-30-6349.75%
2013-03-3112.07%

Annual Net Margin

DateNet Margin
2025-12-31-1419.61%
2023-12-31-368994.20%
2022-12-31-62251.74%
2021-12-31-5468.98%
2020-12-31-502.09%
2016-12-31-171945.07%
2015-12-31-63.62%
2014-12-31-74.01%
2013-12-31-265.63%
2012-12-3123.96%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
Evolus, Inc. (EOLS)United States$0.519B-13.32
ARVINAS, INC. (ARVN)United States$0.510B58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82